However, in a study by Relling et al it was found that when patients were treated with antimetabolites (i.e. mercaptopurine, methotrexate) and prophylactic cranial irradiation as part of their antileukemic therapy, whether they developed a brain tumor depended on their Tpmt status [8], [24]. The gene discussed is TPMT; the disease is brain neoplasm.